Matt joined Imperative Care in October 2020 and brings over 20 years of financial experience in medical technology and biotech fields. Previously, he served as CFO at iRhythm Technologies (IRTC), a publicly traded NASDAQ company that has redefined the way ambulatory cardiac arrhythmias are clinically diagnosed. Matt took the company public in October of 2016. Prior to iRhythm, Matt served as CFO of Navigenics, a company focused on personalized genetic testing to determine if individuals were at risk for certain health conditions. Matt has also served in various financial and business development roles at Corventis, Cogentus, Affymetrix and Guidant Corporation. Matt received his MBA in Finance from the Kelley School of Business in Bloomington, Indiana and his B.A. degree in Finance and minor in sociology from the University of Iowa in Iowa City.

Source: Imperative Care, Inc. on 09/11/2023